Aurobindo Pharma Glenmark Pharmaceuticals

A mutual decision to cancel the agreement was taken as approval from US Federal Trade Commission was not obtained within anticipated timelines

Glenmark Pharma is continuously going down from Rs 600 levels and is not showing any sign of recovery.

Aurobindo Pharmaceuticals, BHEL, Ambuja Cements, Grasim Industries, Zee Entertainment, Glenmark Pharmaceuticals, Lupin and LIC Housing Finance were among the 34 stocks that hit their 52-week lows

Aurobindo Pharma was up 9% at Rs 826, surging 22% in past three trading days after the company on Thursday announced the acquisition of Sandoz's generic business in the US for $900 million.